Iovance Reports Inducement Grants Under NASDAQ Listing Rule
Iovance Biotherapeutics has granted inducement stock options for 62,790 shares to nine new non-executive hires. The options are priced...
eClinical Tech News
Xoma Royalty, Lava Therapeutics Amend Purchase Agreement
XOMA Royalty Corporation has amended its definitive agreement to acquire LAVA Therapeutics, cutting the initial cash consideration to $1.04...
CorMedix Surging, Raises 2025 Net Revenue Guidance
CorMedix posted preliminary third-quarter 2025 results showing more than $100 million in net revenue, at least $85 million from...
OGRD Alliance’s Surging, Successful Growth in Asia, MENA
OGRD Alliance is expanding its PLPC-DB phospholipoproteomic module and its Oncovix documentation program from Dubai into Asia and the...
i-mab to Rebrand as Novabridge, Eyes Hong Kong IPO
I-Mab is pivoting to a new operating model and identity, unveiling plans to rebrand as NovaBridge Biosciences, pursue a...
Iovance Biotherapeutics Reports Inducement Grants for New Hires
Iovance Biotherapeutics has granted inducement stock options covering 62,790 shares to nine new non-executive employees, effective October 16, 2025....
Praxis Sees Positive Phase 3 Results for Essential Tremor
Praxis Precision Medicines reported positive topline results from two Phase 3 studies in its Essential3 program for ulixacaltamide in...
ANI Pharma to Present New Day Trial Data at AAO 2025
ANI Pharmaceuticals will deliver a late-breaking oral presentation of the NEW DAY clinical trial for ILUVIEN (fluocinolone acetonide 0.19...
Rakovina Unveils New CNS-Penetrating ATR Inhibitor Data
Rakovina Therapeutics will present new preclinical data on a series of AI-designed ATR inhibitors with central nervous system penetrance...
Minovia Drug MNV-201 Receives FDA Orphan Drug Designation
Minovia Therapeutics has secured FDA Orphan Drug Designation for MNV-201 in myelodysplastic syndromes, adding to the asset’s existing Fast...